Denise Farnath Alber, MD
Ophthalmology · Pennsville, NJNPI 1134225907
Payments from drug & device makers
Across 39 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$244
- Merz Pharmaceuticals, LLC$105
- Bausch & Lomb Americas Inc.$92
- Merz North America, Inc.$53
- Amgen$42
- Sun Pharmaceutical Industries Inc.$34
- plus $105 from 7 others
What the payments were for
- Food & beverage$676100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $244 |
| Merz Pharmaceuticals, LLC | 4 | $105 |
| Bausch & Lomb Americas Inc. | 6 | $92 |
| Merz North America, Inc. | 2 | $53 |
| Amgen | 3 | $42 |
| Sun Pharmaceutical Industries Inc. | 2 | $34 |
| Thea Pharma Inc. | 1 | $19 |
| Harrow Eye, LLC | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $15 |
| Oyster Point Pharma, Inc. | 1 | $14 |
| Novartis | 1 | $13 |
| Oasis Medical, Inc. | 1 | $13 |
How this compares
$676 in reported general payments places this provider in the 30th percentile of 583 ophthalmology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TobradexTobramycin/Dexamethasone | 12 | $3,636 |
| Bacitracin | 37 | $3,073 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 228 | $2,457 |
| Latanoprost | 60 | $673 |
| Prednisolone Acetate | 15 | $510 |
| ErythromycinErythromycin Base | 34 | $366 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $345 |
| Bacitracin-PolymyxinBacitracin/Polymyxin B Sulfate | 28 | $315 |
| Timolol Maleate | 23 | $304 |
| Doxycycline Hyclate | 43 | $260 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 39 | $108 |
| Diazepam | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Pennsville
- Patrick HigginsBloomfield$16.7M
- Jai ParekhWoodland Park$2.1M
- Eric MannDover$860K
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Luis Gonzalez GonzalezTeaneck$727K
- Cynthia MatossianPennington$726K
- Charles CraneSouth Orange$582K
- Albert KhouriNewark$542K
- Brett BieloryRutherford$477K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.